Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Journal of Theoretical Biology|March 8, 2016
Bistability analyses of CD4+ T follicular helper and regulatory cells during Helicobacter pylori infectionAndrew Leber, Vida Abedi, Raquel Hontecillas, et al.Plos One|December 10, 2016
Modeling the Role of Lanthionine Synthetase C-Like 2 (LANCL2) in the Modulation of Immune Responses to Helicobacter pylori InfectionAndrew Leber, Josep Bassaganya-Riera, Nuria Tubau-Juni, et al.The Journal of Nutrition|May 13, 2011
Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel diseaseJosep Bassaganya-Riera, Margaret DiGuardo, Monica Viladomiu, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2017
Cooperation of Gastric Mononuclear Phagocytes with Helicobacter pylori during ColonizationMonica Viladomiu, Josep Bassaganya-Riera, Nuria Tubau-Juni, et al.Scientific Reports|July 15, 2020
Identification of new regulatory genes through expression pattern analysis of a global RNA-seq dataset from a Helicobacter pylori co-culture systemNuria Tubau-Juni, Josep Bassaganya-Riera, Andrew Leber, et al.Plos One|April 18, 2012
Computational modeling-based discovery of novel classes of anti-inflammatory drugs that target lanthionine synthetase C-like protein 2Pinyi Lu, Raquel Hontecillas, William T Horne, et al.Plos One|September 15, 2015
Modeling the Regulatory Mechanisms by Which NLRX1 Modulates Innate Immune Responses to Helicobacter pylori InfectionCasandra W Philipson, Josep Bassaganya-Riera, Monica Viladomiu, et al.Plos One|October 17, 2012
Modeling the role of peroxisome proliferator-activated receptor γ and microRNA-146 in mucosal immune responses to Clostridium difficileMonica Viladomiu, Raquel Hontecillas, Mireia Pedragosa, et al.Gut Microbes|December 9, 2014
Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrheaDavid T Bolick, Glynis L Kolling, John H Moore, et al.Antimicrobial Agents and Chemotherapy|June 4, 2014
Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pyloriPaul S Hoffman, Alexandra M Bruce, Igor Olekhnovich, et al.Pageof 4